The Latest Cancer Drugs News
Browsing: Cancer Drug News
Targeted delivery of highly toxic anti-cancer drug to brain tumours
With a survival rate of only five years, the most common and aggressive form of…
Antihypertensives can decrease bleomycin-induced lung injury
Bleomycin is a drug used to treat certain cancers, such as Hodgkin lymphoma and germ…
New classification: leukaemia subtypes reveal potential of existing drugs
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…
FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma
On February 5, 2021, the Food and Drug Administration granted accelerated approval to umbralisib, a…
Mathematical method developed to predict cancer and drug-specific immunotherapy efficacy
Researchers from Houston Methodist, USA, have developed a mathematical model to predict how specific cancers…
Drug ‘breakthrough’ gives longest-ever survival in non-resectable liver cancer patients
The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo…
Drug is promising against pancreatic and breast cancers
ProAgio, a drug developed by Georgia State University (USA) biology professor Zhi-Ren Liu and his…
Popular breast cancer drugs don’t work the way we thought they did
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may…
Human pancreatic cancer model offers new opportunities for testing drugs
UNSW scientists have grown human pancreatic cancer tumours in the lab—their model is the first…
Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…